Frederic Kontny

Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial

Lars Wallentin, Bo Lagerqvist, Steen Husted et al. · The Lancet · 2000 · 677 citations

Medicine, Cardiology, Clinical Sciences +13

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Christopher P. Cannon, Robert A. Harrington, Stefan James et al. · The Lancet · 2010 · 661 citations

Medicine, Cardiology, Pharmacology +15

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial

Stefan James, Dominick J. Angiolillo, Jan H. Cornel et al. · European Heart Journal · 2010 · 448 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators.

Lars Wallentin, Eva Swahn, Frederic Kontny et al. · PubMed · 1999 · 338 citations

Medicine, Cardiology, Clinical Sciences +14

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15